Jyseleca

Acquired By Alfasigma
Drug information is provided through the Jyseleca website.

About Jyseleca

Jyseleca is a Healthcare company, and was acquired by Alfasigma in February 2024. Drug information is provided through the Jyseleca website. Its focus areas include Pharmaceutical Product Websites.

Company details

The Jyseleca website is maintained to deliver factual details on pharmaceutical drugs. Content is structured around drug profiles, usage guidelines, and related medical resources within the healthcare information sector. Operations are conducted digitally, serving users seeking reliable medication data. No founding year or physical location is specified, with focus placed on online accessibility for educational purposes in pharmaceuticals.

  • Stage Acquired
  • Sectors
    Healthcare
  • Acquired by Alfasigma (Feb 2024)
Key Metrics

Investors in Jyseleca

Jyseleca has secured backing from 1 investor. Prominent investors backing the company include Alfasigma.

All
InvestorDescriptionFounded YearDomainLocation
Generic tablets, capsules, syrups, and injectables are manufactured.
2015alfasigma.comBologna, Italy
Premium access

Investor details for Jyseleca

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Jyseleca

The Jyseleca website is maintained to deliver factual details on pharmaceutical drugs. Content is structured around drug profiles, usage guidelines, and related medical resources within the healthcare information sector. Operations are conducted digitally, serving users seeking reliable medication data. No founding year or physical location is specified, with focus placed on online accessibility for educational purposes in pharmaceuticals.

Jyseleca has 1 investor. Key investors include Alfasigma.

Yes. Jyseleca was acquired by Alfasigma in February 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available